The Lung Cancer Therapeutics Market 2024 to 2034 is expected to experience a substantial increase in size, growing from USD 37.5 billion in 2024 to USD 112.8 billion by 2034, at a CAGR of 11.7%. This robust expansion is driven by an increase in the global prevalence of lung cancer, advancements in cancer therapeutics, and a growing pipeline of innovative treatment options. Lung cancer remains one of the leading causes of cancer-related deaths worldwide, creating an urgent demand for effective therapies and treatments, thus fueling the market growth. https://www.globenewswire.com/news-release/2024/11/27/2988268/0/en/Lung-Cancer-Therapeutics-Market-Analysis-by-treatment-into-Chemotherapy-Targeted-Therapy-Radiotherapy-and-Biological-Therapy-Through-2034-Future-Market-Insights-Inc.html